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ABSTRACT Streptococcus suis is one of the most important zoonotic bacterial
pathogens of pigs, causing significant economic losses to the global swine industry.
S. suis is also a very successful colonizer of mucosal surfaces, and commensal strains
can be found in almost all pig populations worldwide, making detection of the S.
suis species in asymptomatic carrier herds of little practical value in predicting the
likelihood of future clinical relevance. The value of future molecular tools for surveil-
lance and preventative health management lies in the detection of strains that ge-
netically have increased potential to cause disease in presently healthy animals. Here
we describe the use of genome-wide association studies to identify genetic markers
associated with the observed clinical phenotypes (i) invasive disease and (ii) asymp-
tomatic carriage on the palatine tonsils of pigs on UK farms. Subsequently, we de-
signed a multiplex PCR to target three genetic markers that differentiated 115 S. suis
isolates into disease-associated and non-disease-associated groups, that performed
with a sensitivity of 0.91, a specificity of 0.79, a negative predictive value of 0.91,
and a positive predictive value of 0.79 in comparison to observed clinical pheno-
types. We describe evaluation of our pathotyping tool, using an out-of-sample col-
lection of 50 previously uncharacterized S. suis isolates, in comparison to existing
methods used to characterize and subtype S. suis isolates. In doing so, we show our
pathotyping approach to be a competitive method to characterize S. suis isolates re-
covered from pigs on UK farms and one that can easily be updated to incorporate
global strain collections.
KEYWORDS molecular diagnostics, pathotyping, Streptococcus suis, surveillance,
virulence markers
Streptococcus suis is one of the most important bacterial pathogens of pigs, causingsignificant economic losses to the swine industry worldwide (1). The infectious
agent is responsible for a wide range of clinical manifestations, including septicemia
with sudden death, meningitis, endocarditis, arthritis, and pneumonia, among other
diseases (2). S. suis is also a zoonotic pathogen associated with exposure to pigs or
pork-derived products (3). Although cases in Europe are infrequently reported, in recent
CitationWileman TM, Weinert LA, Howell KJ,
Wang J, Peters SE, Williamson SM, Wells JM,
Langford PR, Rycroft AN, Wren BW, Maskell DJ,
Tucker AW, on behalf of the BRaDP1T
Consortium. 2019. Pathotyping the zoonotic
pathogen Streptococcus suis: novel genetic
markers to differentiate invasive disease-
associated isolates from non-disease-
associated isolates from England and Wales.
J Clin Microbiol 57:e01712-18. https://doi.org/
10.1128/JCM.01712-18.
Editor Brad Fenwick, University of Tennessee
at Knoxville
Copyright © 2019 Wileman et al. This is an
open-access article distributed under the terms
of the Creative Commons Attribution 4.0
International license.
Address correspondence to Thomas M.
Wileman, tmw37@cam.ac.uk, or Alexander W.
Tucker, awt1000@cam.ac.uk.
* Present address: Kate J. Howell, Department
of Paediatrics, Addenbrooke’s Hospital,
Cambridge, United Kingdom.
Received 22 October 2018
Returned for modification 15 November
2018
Accepted 14 March 2019
Accepted manuscript posted online 3 April
2019
Published
CLINICAL VETERINARY MICROBIOLOGY
crossm
July 2019 Volume 57 Issue 7 e01712-18 jcm.asm.org 1Journal of Clinical Microbiology
25 June 2019
 o
n
 June 27, 2019 by guest
http://jcm.asm.org/
D
ow
nloaded from
 
years the surveillance and number of reported human infections have increased
substantially in Southeast Asia (4–9).
Importantly, S. suis is not only an invasive pathogen but also a very successful
colonizer of mucosal surfaces (10). In fact, the upper respiratory tract of pigs, in
particular the palatine tonsils, is considered to be both the natural habitat of S. suis and
a principal route of invasion, although the bacterium can also be recovered from the
gastrointestinal and genital tracts (2). Colonization of adult pigs is common in almost
all pig populations sampled, meaning that transfer of S. suis from sow to piglet during
parturition and suckling is an important route of transmission (10).
Several methods exist to investigate strain diversity and identify phylogenetic
groups of S. suis. Simple biochemical tests cannot always differentiate S. suis from S.
suis-like strains when performed on cultured isolates recovered from diseased animals
and to date remain of little practical use in differentiating invasive disease-associated
strains from asymptomatic commensal-like strains, both of which may contribute
subclinically to the respiratory microflora of colonized pigs (1). Other existing methods
used to characterize and subtype S. suis as part of epidemiological studies have recently
been the subject of a comprehensive review by Xia et al. (11). Each approach has its
limitations, often requiring either large amounts of sample DNA, which are labor-
intensive and cumbersome to obtain, or high levels of technical competence, making
the comparison of results between laboratories difficult.
To date, serotyping remains the most widely used method to subtype S. suis isolates
and is an important part of the routine diagnostic procedure (2, 12). A total of 35
serotypes have been described for S. suis based on differences in the capsular poly-
saccharide antigens, but since their original descriptions, evidence has emerged for the
reclassification of a number of serotypes as other Streptococcus species, meaning that
current opinion considers there to be just 29 “true” S. suis serotypes (namely, 1 to 19,
21, 23 to 25, 27 to 31, and 1/2) (13). Serotype 2 predominates among clinical cases
of disease in most countries, although serovars 1 to 9, 14, and 1/2 have all been
documented as being of clinical importance in certain geographical locales (14–18). As
a result, serotyping has been used as a proxy for predicting the virulence potential of
S. suis isolates. However, the use of serotyping alone as a predictor of virulence has the
limitation that strains of the same serotype can vary substantially in virulence (19, 20).
Given the limitations of serotyping to reliably predict virulence potential of S. suis
strains, other markers have been investigated. A wide range of homologs of bacterial
virulence factors and virulence-associated factors found in other Gram-positive organ-
isms has been shown to affect the virulence of S. suis strains through targeted-
mutagenesis studies (21–23). However, a clear association with specific roles in the
onset and development of disease has not been found for many proposed factors
(24, 25). Despite this, the “virulence-associated markers” (rather than virulence
factors per se) extracellular protein factor (EF; encoded by the epf gene) (26) and
muramidase-released protein (MRP; encoded by the mrp gene) (27), as well as the
thiol-activated toxin hemolysin suilysin (SLY; encoded by the sly gene) (28, 29), have
been extensively used to predict the virulence potential of S. suis strains in certain
mainly European countries, particularly for strains of serotype 2 (17, 24, 30).
Unfortunately, genotyping of epf, mrp, and/or sly also fails to provide clear classi-
fication of a S. suis isolate as virulent (or not) because isogenic mutants devoid of
such factors have been found to be as virulent as their respective parental strains,
emphasizing the importance of their consideration as virulence-associated markers
rather than true virulence factors per se (31).
Advances in sequencing technologies now allow whole-genome sequencing (WGS)
of multiple strains of the same species, including S. suis (32–36). This explosion in the
amount of detailed genetic information has allowed Bayesian analysis of population
structure and the investigation of S. suis recombination rates, revealing enormous
species diversity and significant genomic differences between S. suis isolates respon-
sible for systemic disease in pigs compared to nonclinical isolates recovered from the
upper respiratory tract (35). Indeed, in 2015 Weinert et al. proposed that loss of
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protein-encoding sequences had led to a smaller systemic disease-associated genome
with increased virulence potential and an overrepresentation of genes encoding pre-
viously reported virulence factors associated with S. suis (35).
Minimum core genome (MCG) sequence typing is a recently described typing
scheme that also takes advantage of the increase in available S. suis WGS data, using
population genetics-based subdivisions for strain identification and typing (33, 37).
MCG sequence typing exploits advances in next-generation sequencing to identify
novel regions of the core genome that can be used to identify and type S. suis isolates
into “MCG groups” that can later be associated with clinical phenotypes. In fact, during
the design of this method, MCG group 1 was reported as being assigned to all highly
virulent isolates tested and associated with the greatest occurrence of previously
reported virulence genes (33). However, MCG sequence typing, like multilocus se-
quence typing (MLST) also described for S. suis (38), is difficult to apply to routine
diagnostic testing and can sometimes lack the discriminatory power to differentiate
bacterial strains into virulent and avirulent subpopulations, limiting its usefulness in
epidemiological studies.
The aim of this study was to design and then evaluate a pathotyping tool to predict
the virulence potential of S. suis isolates using genome-wide association studies, a
so-far-unexploited method for the identification of S. suis virulence-associated markers.
The statistical power to allow the identification of robust associations between geno-
type and phenotypes, including virulence in many different bacterial species, is now
possible due to the rapid increases in the availability of detailed WGS data (39, 40). In
this study, we have combined WGS data with high-quality clinical metadata in order to
identify genetic markers in the S. suis accessory genome (i.e., genes absent from one or
more isolates or unique to a given isolate) associated with (i) invasive disease or (ii)
asymptomatic carriage on the palatine tonsils of pigs on UK farms. Subsequently, we
designed a multiplex PCR (mPCR) to target three genetic markers that differentiated
115 S. suis isolates into (i) invasive disease-associated and (ii) non-disease-associated
groups. We also describe evaluation of our pathotyping tool (generalized linear model
and mPCR), using an out-of-sample collection of 50 previously uncharacterized S. suis
isolates, in comparison to existing methods used to characterize and subtype S. suis
isolates. In doing so, we show our approach to be a competitive method to subtype S.
suis isolates recovered from pigs on UK farms and one that can easily be updated to
incorporate global strain collections.
MATERIALS AND METHODS
Bacterial isolates. Two groups of S. suis isolates were used in this study, (i) a training collection of
115 isolates and (ii) an out-of-sample test collection of 50 previously uncharacterized isolates. The
original training collection was used to identify genetic markers which could differentiate S. suis isolates
into (i) invasive disease-associated and (ii) non-disease-associated phenotypic groups. The training
collection consisted of laboratory reference strain P1/7 (GenBank accession number NC_012925), origi-
nally recovered from an antemortem blood culture from a pig that died with meningitis in the United
Kingdom (32, 41). The other 114 isolates of the training collection were a subset recovered from pigs on
farms in England and Wales during routine diagnostic investigations at the Animal Health and Veterinary
Laboratories Agency (AHVLA; now the Animal and Plant Health Agency [APHA]) in 2010, and contribute
to a larger collection previously described in 2015 by Weinert et al. (35). Well-defined phenotypic
metadata were available based on which each isolate was categorized as being associated with invasive
S. suis disease (n 53; recovered from systemic sites in the presence of clinical signs [arthritis, meningitis,
and septicemia] and/or gross pathology consistent with S. suis infection) or as being non-disease
associated (n 62; recovered from the tonsil or trachea-bronchus of pigs without any typical signs of
streptococcal disease but diagnosed with disease unrelated to S. suis, such as enteric disease). The
out-of-sample test collection was used to evaluate our pathotyping tool. Out-of-sample forecasting is a
common approach used to evaluate the performance of binary diagnostic tests. To avoid reducing
statistical power, rather than split the training collection, an additional out-of-sample “test” collection
was put together consisting of 23 invasive disease-associated (recovered from systemic, nonrespiratory
locations of pigs diagnosed with S. suis disease at the APHA during 2013) and 27 non-disease-associated
isolates (recovered from material scraped from the palatine tonsils of pigs exhibiting no signs of S. suis
disease on farms in England and Wales between June 2013 and May 2014). Sites of recovery and ante-
and postmortem findings of all isolates described in this study are summarized in Table S1 in the
supplemental material.
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Identification of genetic markers associated with observed clinical phenotype. Genetic markers
to pathotype S. suiswere identified using positive detection data of putative protein-encoding sequences
making up the S. suis accessory genome (i.e., genes absent from one or more isolates or unique to a given
isolate). The accessory genome was taken from Weinert et al. (35). Briefly, de novo assemblies of Illumina
fastq reads were produced and protein-encoding genes identified, that were then used in Markov
clustering to find orthologue groups. Two complementary genome-wide association studies, (i) the
univariate chi-squared test for independence and (ii) the multivariate discriminant analysis of principal
components (DAPC), were combined to define a preliminary list of genetic markers associated with the
observed clinical phenotypes (i) invasive disease and (ii) asymptomatic carriage on the palatine tonsils of
pigs. The chi-squared test for independence, implemented in the R package stats (42), was used to
compare the observed positive detection of protein-encoding sequences with expected frequencies, in
doing so calculating a test statistic that if greater than the critical value was reason to reject the null
hypothesis of independence (P value  0.05). Bonferroni adjustment (/n) was used to control for
family-wise error associated with multiple sampling.
DAPC (43, 44), implemented in the R package adegenet (45, 46), was used to identify genetic
differences between predefined phenotypic groups. The total amount of original variation retained in the
DAPC model affected which genetic markers contributed most to the separation of genetic structures.
As a result, four independent DAPC analyses were performed retaining 60, 70, 80, or 90% of the original
genetic variation, and the 1% of ranked genetic markers contributing most to the discrimination of
predefined phenotypic groups was then analyzed and genetic markers consistently output by two or
more DAPC analyses taken forward as candidates for pathotyping S. suis.
Analysis of the distribution of previously reported virulence factors associated with S. suis
disease. Protein-encoding sequences present in P1/7, taken from the list of previously published
virulence and virulence-associated factors compiled as part of a comprehensive review by Fittipaldi et al.
(24), were extracted from GenBank (Table S2). P1/7 protein-encoding sequences were used as tBLASTn
queries against a bespoke BLAST database consisting of the draft genome assemblies of all isolates
described in this work. Amino acid level matches to80% of80% of the total length of each translated
protein-encoding sequence were considered hits.
Selection of genetic markers to pathotype S. suis. Logistic regression analysis in the form of a
generalized linear model (GLM) with backwards-stepwise selection using penalized likelihood ratio tests,
implemented in the R package logistf (47), was used to identify the fewest statistically significant (P value 
0.05) markers to differentiate S. suis isolates into predefined (i) invasive disease-associated and (ii)
non-disease-associated groups. A receiver operating characteristic (ROC) curve, implemented in the R
package ROCR (48), was used to visualize the GLM performance metrics true-positive rate (sensitivity) and
false-positive rate (1  specificity) in comparison to the observed clinical phenotype (considered to be
the “gold standard” in this study), and a cutoff threshold was selected to convert the real-valued output
(fitted values) of the logistic regression (probability of causing invasive disease) into a binary class
decision: invasive disease-associated (1)/non-disease associated (0). As no cutoff was optimal according
to all possible performance criteria, the cutoff choice involved a trade-off between different performance
metrics where a low false-negative rate (1  sensitivity, analogous to type II error) was chosen as the
most valuable performance metric for pathotyping S. suis, with a view to establish and then maintain a
pig population free of invasive disease-associated strains.
All statistical analyses were performed using the standard R environment for statistical computing
and graphs (version 3.1.1) (49).
Identification of S. suis-species specific genetic markers. We designed an mPCR to target genetic
markers associated with observed clinical phenotype, along with an S. suis species-specific marker as a
positive control. The most conserved protein-encoding sequences of the S. suis core genome (i.e., present
in all isolates) were used to select a species-specific marker to complement the pathotyping markers. To
do this, all annotated protein-encoding sequences of S. suis strain P1/7 were used as BLASTn queries
against a bespoke BLAST database of all de novo assemblies and known S. suis complete genome
sequences. Protein-encoding sequences with identities of95% across80% of the total length of each
query sequence were then used to query the NCBI nonredundant (nr) database to identify matches only
to S. suis.
Multiplex PCR and detection of PCR amplicons. The software primer3 version 4.0.0 (http://primer3
.ut.ee) was used to design mPCR primers. All mPCR primers were designed to target conserved regions
within the protein-encoding sequence of genetic markers (as opposed to flanking regions) and are
summarized in Table 1. Primers were designed to have similar physical characteristics, enabling simul-
taneous amplification under the same thermal cycling conditions and in multiplex reactions. Primer
length (21 to 30 bp), GC content (40 to 60%), melting temperature (68°C if possible but at least 60°C),
and expected amplicon size (100 to 1,000 bp) were based on the manufacturer’s recommendations for
primer design using the Multiplex PCR Plus kit (Qiagen). Consistency between the positive detection of
genetic markers and primer matches was investigated using BLASTn. Prior to ordering, all primers were
queried against the NCBI nr nucleotide database to check for non-S. suis DNA matches. Primers were
synthesized by Sigma-Aldrich (Haverhill, United Kingdom) and delivered in solution (TE buffer; 10 mM
Tris-Cl, 1 mM EDTA [pH 8.0]) at a stock concentration of 100 M; primers were used at a working stock
concentration of 20 M.
All mPCRs were performed using the Multiplex PCR Plus kit (Qiagen) and, unless otherwise stated,
contained the same reagents except for template DNA. The reaction mixture (50 l) for each mPCR
consisted of 25 l of 2 Multiplex PCR master mix, 5 l of 10 CoralLoad dye, 10 l of RNase-free water,
0.2 M (final concentration) of each primer, and 10 ng of template DNA. The three-step thermal cycling
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program for all reactions was as follows: 95°C for 5 min, followed by 35 cycles of 95°C for 30 s
(denaturation), 66°C for 90 s (annealing), and 72°C for 90 s (extension), with a final extension of 68°C for
10 min using a T100 thermal cycler (Bio-Rad).
PCR products were analyzed by gel electrophoresis using 2% (wt/vol) UltraPure agarose (Invitrogen)
gels made with 1 Tris-borate-EDTA (TBE) buffer and containing 1 SYBR Safe DNA gel stain (Invitro-
gen). Running time was 60 min at a constant 100 V. Results were visualized using a GelDoc imager
(Bio-Rad). Where appropriate, mPCR products were purified using the QIAquick PCR purification kit
(Qiagen) as per the manufacturer’s instructions and Sanger sequenced using the Source Bioscience
Lifesciences sequencing service. Returned sequencing data were aligned with reference sequences of the
target protein-encoding sequence using CodonCode Aligner software (CodonCode Corporation).
The approximate limit of detection of the mPCR was estimated from 10-fold serial dilutions of S. suis
genomic DNA of known concentration. DNA extracted from four isolates of the training collection
representing invasive disease-associated (SS002 and SS004) and non-disease-associated (LSS011 and
LSS027) phenotypes/genotypes was mixed in equal quantities so that templates for each mPCR amplicon
would be present in all reactions. A series of 10-fold dilutions was then performed to create mPCR
templates of decreasing concentration. The limit of detection was considered to be the lowest concen-
tration of template DNA from which all predicted mPCR amplicons, after 35 thermal cycles, were easily
visible under UV transillumination.
To evaluate the specificity of the mPCR assay for S. suis, field isolates of Streptococcaceae commonly
recovered from the upper respiratory tract of pigs on farms in England and Wales were used as a panel
of negative controls. The collection included isolates of Streptococcus gallolyticus, Streptococcus orisratti,
Streptococcus pneumoniae, and Streptococcus uberis, sourced from Biotechnology and Biological Sciences
Research Council (BBSRC) research project BB/L003902/1. In addition, commensal Pasteurellaceae, in-
cluding Actinobacillus indolicus, Actinobacillus minor, Actinobacillus porcinus, and Haemophilus parasuis
(Nagasaki and SW140), were also included, as well as DNA from an Alcaligenaceae isolate, Bordetella
bronchiseptica RB50 (GenBank accession number NC_002927) (50).
Comparison of our pathotyping tool to existing methods used to subtype disease-associated
isolates of S. suis. To compare our pathotyping tool (GLM and mPCR) to published methods used to
subtype disease-associated isolates of S. suis, the molecular serotype, virulence-associated gene (epf,mrp,
and sly) profile, MLST, and MCG sequence type were all determined in silico. For comparison of our
pathotyping tool against each existing method, the original training collection was used to “train” a
model that was then applied to the out-of-sample test collection.
Traditional serotyping (by capillary precipitation) data were unavailable for all S. suis isolates
described in this study; therefore, molecular serotyping was performed using an adaptation (for in silico
use) of the mPCR assays described by Liu et al. (51). Primer sequences were used as BLASTn queries, and
nucleotide level matches to95% of the total length of each primer sequence were considered hits. The
distance between hits was compared to reported PCR amplicon sizes. Isolates that could not be assigned
to one of the 35 (1 to 34 and 1/2) originally described S. suis serotypes were deemed nonserotypeable
(NT). Differentiation of molecular serotypes 1 from 14 and 2 from 1/2 was performed using the method
described by Athey et al. (52). All isolates, in particular those deemed to be NT, were confirmed to be S.
suis using a combination of (i) biochemical profile (API 20 Strep), (ii) MLST data, and (iii) recN sequence
homology (53).
Virulence-associated gene profiling was performed using an adaptation (for in silico use) of the
method described by Silva et al. (54). Again, mPCR and singleplex PCR primer sequences were used as
BLASTn queries and nucleotide level matches to95% to the total length of each primer sequence were
considered hits. The distance between hits was compared to reported PCR amplicon sizes. Logistic
regression (as described above) using the prevalence of epf, mrp, and/or sly as the GLM explanatory
variables was used to classify all isolates as (i) invasive disease associated or (ii) non-disease associated.
MLST was performed using the software MLST version 2.0 (http://cge.cbs.dtu.dk) (55).
MCG sequence typing was performed using an adaptation (for in silico use) of the method described
by Zheng et al. (37). Multiplex PCR primer sequences were used as BLASTn queries and nucleotide level
matches to 95% of the total length of each primer sequence were considered hits. The distance
between hits was compared to reported mPCR amplicon sizes. Nucleotide sequences between primer
sequence matches were then extracted aligned against the MCG typing reference strain GZ1 (GenBank
accession number CP000837), and the 10 single nucleotide polymorphisms (SNPs) of interest were called,
allowing isolates to be assigned to one of the seven reported MCG groups for S. suis.
McNemar’s chi-squared test for count data, implemented in the R package stats (42), was used to test
for statistically significant differences in the sensitivities and specificities of two binary diagnostic tests in
a paired study. The weighted generalized score statistic for comparison of predictive values as proposed
by Kosinski (56), implemented in the R package DTComPair (57), was used to test for significant
differences in (negative and positive) predictive values of two binary diagnostic tests.
RESULTS
Design of a pathotyping tool for S. suis. Genetic markers to pathotype S. suis were
identified using positive detection data of 7,261 putative protein-encoding sequences
making up the S. suis accessory genome (35). To do this, the output of two comple-
mentary genome-wide association studies were combined to define a preliminary list
of 497 genetic markers associated with the observed clinical phenotypes (i) invasive
disease and (ii) asymptomatic carriage on the palatine tonsils of pigs. A multistep
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process was used to reduce the preliminary list to a number suitable for logistic
regression analysis, retaining genetic markers only if (i) positively detected in 50% of
invasive disease-associated and 50% of non-disease-associated isolates (and vice
versa, i.e., 50% of invasive disease-associated and 50% of non-disease-associated
isolates; n 88 remaining), (ii) the protein-encoding sequence length was 500 bp
(based on the manufacturer’s recommendations for primer design using the Qiagen
Multiplex PCR Plus kit; n 44 remaining), and (iii) not predicted to be a mobile genetic
element, such as a phage gene, integrase, or transposon (based on Prokka annotations;
n 14 remaining). A GLM with backwards-stepwise selection using penalized likeli-
hood ratio tests was then used for the final selection of genetic markers, two associated
with invasive disease and one associated with asymptomatic carriage (Table 1). A
receiver operating characteristic (ROC) curve was used to visualize the GLM perfor-
mance metrics true positive rate (sensitivity) and false-positive rate (1 specificity) and
select the cutoff threshold of 0.43 to be used to convert the real-valued output (fitted
values) of the GLM into a binary class decision: invasive disease associated or non-
disease associated (Table S1). In comparison to the observed clinical metadata, con-
sidered the gold standard in this study, our three genetic markers subtyped the 115 S.
suis isolates of the training collection with a sensitivity of 0.91, specificity of 0.79,
negative predictive value of 0.91, and positive predictive value of 0.79 (Table S3a).
At present, WGS is not readily available for routine surveillance studies in veterinary
diagnostics laboratories; therefore, we designed an mPCR to target the three genetic
markers selected to pathotype S. suis. In addition to genetic markers selected to
differentiate S. suis isolates into (i) invasive disease-associated and (ii) non-disease-
associated groups, we also incorporated an S. suis species-specific marker into our
mPCR assay. To do this, we first identified the most conserved protein-encoding
sequences contributing to the S. suis core genome (i.e., present in all isolates) and
selected SSU0577 as a novel S. suis species-specific marker; this marker had a minimum
nucleotide sequence identity of 98.15% across the total length of the 918-bp protein-
encoding sequence.
Evaluation of our pathotyping mPCR with the original training collection.
Figure 1 shows an example of the mPCR amplicon patterns after gel electrophoresis on
a 2% (wt/vol) agarose gel and photographed under UV transillumination. Amplicons of
722 bp correspond to the S. suis species-specific marker (SSU0577) and were produced
FIG 1 Agarose gel showing the multiplex PCR amplicons produced from genomic DNA of eight invasive disease-
associated and six non-disease-associated isolates of S. suis recovered from pigs on farms in England and Wales.
PCR amplicons were electrophoresed on a 2% (wt/vol) agarose gel containing 1 SYBR Safe DNA gel stain for 60
min at a constant 100 V and photographed under UV transillumination. Multiplex PCR amplicon patterns matched
anticipated amplicon patterns based on in silico analyses for all isolates described here. Isolate names are indicated
above lanes. Lane M contains 1 Bioline HyperLadder 100 bp Plus DNA ladder, with sizes indicated on the left
(base pairs). Multiplex PCR amplicon sizes are indicated on the right (base pairs).
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by all isolates of the training collection irrespective of invasive disease-associated/non-
disease-associated phenotype or genotype. Other amplicons of 211 bp and 347 bp
correspond to the invasive disease-associated markers SSU0207 and SSU1589, respec-
tively, and amplicons of 892 bp correspond to the non-disease-associated marker
SSUST30534.
To determine the analytical sensitivity of the mPCR, the approximate limit of
detection was estimated from 10-fold serial dilutions of S. suis genomic DNA of known
concentration. The limit of detection was estimated to be0.0001 ng of S. suis genomic
DNA (equivalent to 45 genome copies), the lowest concentration of template DNA
from which all predicted mPCR amplicons, after 35 thermal cycles, were easily visible
under UV transillumination (data not shown).
To evaluate the specificity of our mPCR for S. suis, field isolates of Streptococcaceae,
Pasteurellaceae, and Alcaligenaceae commonly recovered from the upper respiratory
tracts of pigs on farms in England and Wales were used as a panel of negative controls.
No mPCR amplicons, after 35 thermal cycles and gel electrophoresis, were visible under
UV transillumination for any of the panel of 10 negative controls (data not shown).
Evaluation of our pathotyping tool with an out-of-sample collection. Further
evaluation of our pathotyping tool (GLM and mPCR) was done using an out-of-sample
test collection of 50 previously uncharacterized (genetically) S. suis isolates (23 invasive
disease associated and 27 non-disease associated). Template DNA extracted from each
of the 50 isolates produced the 722-bp mPCR amplicon corresponding to the S. suis
species-specific marker SSU0577. For each isolate, the presence/absence of mPCR
amplicons was then put into the GLM and the cutoff threshold of 0.43 applied to the
fitted values to generate the binary classification decision. Figure 2a summarizes the
classification of the out-of-sample test collection isolates in comparison to the observed
clinical metadata, resulting in a sensitivity of 0.83, specificity of 1.00, negative predictive
value of 0.87, and positive predictive value of 1.00.
Comparison of our pathotyping tool to existing methods used to subtype
disease-associated isolates of S. suis. To compare our pathotyping tool to the use of
serotype as a proxy to predict the virulence potential of S. suis isolates, the serotypes
most frequently recovered from diseased pigs (1 to 9, 14, and 1/2) were considered a
marker of disease association and all other serotypes considered markers of non-
disease association. Figure 2b summarizes the classification of the out-of-sample test
collection isolates in comparison to the observed clinical metadata and shows that the
use of molecular serotypes 1 to 9, 14, and 1/2 to predict disease-association performed
with a sensitivity of 0.87 (n 3 type II errors), not statistically different from our new
mPCR pathotyping tool (P value 0.31731, McNemar’s chi-squared test for count data).
Other performance metrics for the molecular serotype-based approach were a signif-
icantly worse positive predictive value, 0.77 (weighted generalized score statistic for
comparison of predictive values, P value  0.01149), and a significantly worse speci-
ficity, 0.78 (n 8 type I errors; P value 0.01431, McNemar’s chi-squared test for count
data); no statistically significant difference in negative predictive value was observed
(weighted generalized score statistic for comparison of predictive values, P value 
0.90553).
To compare our pathotyping tool to the use of epf, mrp, and/or sly for the
identification of virulent S. suis strains, first a GLM was fitted to the prevalence data of
these virulence-associated genes in the original training collection of S. suis isolates
and, using the same selection criteria as previously described for the pathotyping
markers, a ROC curve used to select the cutoff of 0.12 to convert the GLM fitted values
into a binary class decision. The predict function, implemented in the R package logistf
(47), was then used to generate fitted values for the isolates in the out-of-sample test
collection (Table S1). Figure 2c summarizes the classification of the out-of-sample test
collection isolates as invasive disease associated and non-disease associated based on
the positive detection of epf, mrp, and/or sly in comparison to the observed clinical
phenotype. The combined virulence-associated markers performed with a sensitivity of
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0.96 (n 1 type II errors), not statistically different from our new mPCR pathotyping
tool (P value  0.08326). Other performance metrics for the virulence-associated
genotyping approach were a significantly worse positive predictive value, 0.46 (P
value 2.97708e7; incidentally performing no better than chance [exact binomial test
P value  1]), and a significantly worse specificity, 0.04 (P value  3.41417e7). The
negative predictive value was calculated to be 0.50, worse but not statistically signif-
icantly different (P value  0.07853).
We compared our pathotyping tool to the use of the MLST scheme of King et al. (38)
as a proxy to predict the virulence potential of S. suis isolates. Sequence type 1 (ST1)
was assigned to 70% of disease-associated isolates and 3% of non-disease-associated
isolates of the training collection (Table S1). As ST1 is mostly associated with disease in
both pigs and humans in Europe (12), we used assignment to ST1 as a binary classifier
to indicate disease association in comparison to the observed clinical metadata. Figure 2d
FIG 2 Contingency tables used to calculate the performance metrics summarizing the classification of Streptococcus suis isolates in the out-of-sample test
collection (n 50). Each panel compares the observed clinical phenotype, considered the gold standard in this study, to the use of (a) the newly described
pathotyping markers, (b) serotypes (1 to 9, 14, and 1/2), (c) virulence-associated markers (epf, mrp, and/or sly), (d) multilocus sequence type (MLST) 1, and (e)
assignment to minimum core genome (MCG) sequence type 1 as markers of invasive disease.
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summarizes the classification of the out-of-sample test collection isolates as invasive
disease associated and non-disease associated based on the assignment to ST1 in
comparison to the observed clinical phenotype. Assignment to ST1 performed with a
sensitivity of 0.70 (n 7 type II errors), worse than our pathotyping tool but not a
statistically significant difference (P value  0.08326). The negative predictive value
was calculated to be 0.79, again worse but not a statistically significant difference
(P value  0.08294). Other performance metrics (specificity and positive predictive
value) were found to be identical to our pathotyping tool.
Finally, we compared our pathotyping tool to the use of the MCG typing scheme of
Zheng et al. (33, 37), one of the most recent typing schemes that exploits advances in
next-generation sequencing to identify virulent S. suis strains. MCG group 1 was
assigned to 77% of disease-associated isolates and 3% of non-disease-associated
isolates of the training collection (Table S1). Together with the report of MCG group 1
being assigned to all highly virulent isolates tested during design of the typing scheme
(33), we used assignment to MCG group 1 as a binary classifier to indicate disease
association. Figure 2e summarizes the performance of MCG group 1 in comparison to
the observed clinical metadata. Assignment to MCG group 1 performed with a sensi-
tivity of 0.78 (n 5 type II errors), again worse than our pathotyping tool but not a
statistically significant difference (P value 0.31731). The negative predictive value was
calculated to be 0.84, also worse but not statistically significantly different (P value 
0.31725). Other performance metrics (specificity and positive predictive value) were
found to be identical to our pathotyping tool.
DISCUSSION
We have described the design of a pathotyping tool (GLM and mPCR) exploiting the
identification of genetic markers in the S. suis accessory genome (i.e., genes absent from
one or more isolates or unique to a given isolate) associated with the observed clinical
phenotypes (i) invasive disease and (ii) asymptomatic carriage on the palatine tonsils of
pigs on UK farms. Initial analyses of the original training collection were unable to
identify any single genetic marker of invasive disease prevalent in 95% of invasive
disease-associated isolates and not positively identifiable in 5% of non-disease-
associated isolates. Furthermore, we found that over half (n 40) of published putative
virulence factors, extracted from the previous comprehensive review by Fittipaldi et al.
(24) and present in P1/7, did not show a strong relationship with observed clinical
phenotype, as they were either (i) positively detected in the S. suis core genome (i.e.,
prevalent in all isolates; n 38) or (ii) not detected by our methods in any of the 115
isolates of the training collection (n 2 [data not shown]). The reason for this is unclear,
although it could be an effect of previous studies being limited to small numbers of
isolates often restricted to serotype 2 (58) or of varied and inconsistent animal models
between research groups (25).
To avoid restricting our analyses to previously published reports and not taking full
advantage of the statistical power of our WGS data set, we used two complementary
genome-wide association studies and then logistic regression analysis for the final
selection of genetic markers to pathotype S. suis. Using logistic regression analysis also
allowed for the possibility that multiple genetic markers might best describe the S. suis
pathotype. Our pathotyping markers assigned the 115 S. suis isolates of the original
training collection to phenotypic groups (disease associated and non-disease associ-
ated) with a sensitivity of 0.91 (i.e., the proportion of isolates recovered from systemic
sites and predicted to be disease-causing isolates), a specificity of 0.79 (i.e., the
proportion of isolates recovered from the upper respiratory tract of pigs without any
typical signs of S. suis infection and predicted to be non-disease-associated isolates), a
negative predictive value of 0.91 (i.e., the proportion of isolates predicted to be
non-disease associated that were actually recovered from the upper respiratory tract of
pigs without any typical signs of S. suis infection), and finally, a positive predictive value
of 0.79 (i.e., the proportion of isolates predicted to be associated with invasive disease
that were actually recovered from a systemic site).
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An important caveat of our pathotyping tool design is consideration of the observed
clinical phenotype associated with each isolate as the gold standard to characterize S.
suis isolates as disease associated or non-disease associated. In the absence of an
agreed-upon superior approach, clinical metadata were used to assign S. suis isolates to
one of two phenotypic groups; it is acknowledged that such an approach is not perfect,
as not all additional factors can be accounted for, such as host immune status,
concurrent infections, or environmental conditions that could influence the suscepti-
bility of a host to S. suis-associated disease. Indeed, reports of in vivo challenge studies
can be readily found in the S. suis literature, although most describe data limited to a
small number of isolates, often restricted to serotype 2 (58), and under very different
conditions, making the extrapolation of findings difficult to interpret. An ideal standard
would require an agreed-upon panel of isolates for which a series of consistently
controlled experimental infection challenge studies had been undertaken using pigs of
identical immune status and genetics. However, in order for this to happen, experts in
the field must first agree on a suitable model and set of well-defined criteria to score
virulence (25, 59, 60).
Another important caveat of our pathotyping tool design is the source of S. suis
isolates of the original training collection that were deemed to be non-disease asso-
ciated. While all efforts were made to accurately define invasive disease-associated and
non-disease-associated phenotypic groups, it should be acknowledged that non-
disease-associated isolates of the original training collection were recovered from
routine submissions to the APHA in 2010 and that these pigs were not healthy, even
though they did not show signs of typical streptococcal disease; instead, clinical
features were consistent with different noninfectious diseases or disease caused by
other, non-S. suis infectious agents. Indeed, 13 isolates of the original training collection
deemed to be non-disease associated by phenotype were predicted by our pathotyp-
ing tool to have the potential to cause invasive disease. These 13 type I errors (or false
positives) in comparison to the observed clinical metadata could in fact be true
predictions and examples of S. suis strains with the potential to cause invasive disease
being carried in the upper respiratory tract of pigs on UK farms. Therefore, it is possible
that the mortality of these 13 pigs was due to clones of isolates recovered from the
palatine tonsils or trachea-bronchus yet was not identified as so due to a concurrent or
opportunistic infection presenting a more obvious phenotype, such as diarrhea. Such
an observation is supported by evidence in the literature reporting that virulent strains
of S. suis can be isolated from the tonsils of pigs without obvious streptococcal disease
(61, 62), which is likely to represent carriage of invasive disease-causing strains by pigs
that have mounted an effective immune response.
We deemed the false-negative rate (1  sensitivity) to be the most valuable
performance metric for a S. suis pathotyping tool in order to establish and maintain a
pig population free of invasive disease-associated S. suis strains. During out-of-sample
testing, the false-negative rate of 0.17 corresponded to four false negatives (or type II
errors) where non-disease-associated pathotyping tool predictions were made for
isolates linked with invasive disease clinical metadata. It is interesting to speculate at
the reasons for such observations. Often S. suis strains are described as opportunistic or
secondary pathogens that without a weakened host immune status (due to stress or
concurrent infection) would normally be carried asymptomatically, contributing to the
normal oral microflora of pigs. This may be the explanation for the differences observed
between our pathotyping tool prediction and the observed clinical phenotype, again
emphasizing the fallibility of the phenotype assigned when it is based on field sampling
without carefully controlled infection challenge data.
Comparison to published methods revealed our molecular pathotyping tool to be a
competitive method to subtype S. suis isolates, even though the necessarily small
number of clinically phenotyped isolates in the out-of-sample collection limited the
statistical power of the comparison. Comparing the commonly used performance
metrics sensitivity, specificity, negative predictive value, and positive predictive value,
we found the use of (i) serotypes 1 to 9, 14, and 1/2, (ii) a GLM based on the positive
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detection of virulence-associated markers epf, mrp, and/or sly, (iii) assignment to MLST
1, and (iv) assignment to MCG group 1 showed sensitivities statistically similar to that
of our pathotyping tool. However, the trade-off for high sensitivities was significantly
worse specificities and negative predictive values when using serotypes 1 to 9, 14, and
1/2 or the virulence-associated markers epf, mrp, and/or sly, in certain cases performing
no better than chance (P value 1) in comparison to our pathotyping tool. Overall, the
performance of our pathotyping tool was at least statistically similar to and competitive
with, and in some cases better than, previously described methods for assessing the
clinical significance of S. suis isolates. Similarly, performance of our newly proposed S.
suis species-specific marker (SSU0577) was encouraging. An important consideration
regarding our pathotyping tool, due to the presence of S. suis-like organisms such as
Streptococcus orisratti in the pig upper respiratory tract, we acknowledge that the
specificity of SSU0577 for S. suis and not S. suis-like organisms needs to be extended
and studied further against markers such as recN.
At present, the role in pathogenesis of our newly defined pathotyping markers is
unknown. Based on predicted biological functions (Table 1), we speculate that marker
SSU0207, predicted to be a copper-exporting ATPase, might allow S. suis to avoid
copper toxicity inside phagocytes, as copper homeostasis has been shown to be
important in many bacterial species (63–65). The marker SSU1589 is annotated as a type
I restriction-modification (RM) system S protein in S. suis strain P1/7. Ubiquitous among
prokaryotes, type I RM systems are large multifunctional protein complexes thought to
defend host bacteria from foreign DNA borne by bacteriophages, and they have
recently been described for P1/7 and S. suis strains isolated in the Netherlands (66, 67).
Considered primitive immune systems in bacteria, it has been proposed that the range
of functions RM systems may have should be expanded to include stabilizing mobile
genetic elements or gene regulation, potentially providing evolutionary fitness advan-
tages and virulence under certain conditions (68). Indeed, the proposed role in pro-
tection against foreign DNA may merely be a coincidental benefit of these functions
(69). In fact, a type I RM system in Streptococcus pneumoniae which can undergo genetic
recombination with truncated variants of the same gene to generate alternative
variants with different methylation specificities could control global changes in gene
expression (70). In Streptococcus pneumoniae there is a selection for variants of this
genetic switching in vivo, indicating a role in systemic disease.
Our third genetic marker (SSUST30534), a putative sugar ABC transporter, was
positively associated with the non-disease-associated phenotype (asymptomatic
commensal-like carriage). The practical application of the genetic marker positively
associated with asymptomatic carriage might not be immediately obvious, but its
statistical significance in the GLM is noteworthy. Indeed, gene loss (of so-called anti-
virulence genes) in the evolution of bacterial pathogens from nonpathogenic com-
mensal strains could be a mechanism of fine-tuning pathogen genomes for maximal
fitness in new host environments; in short, when regulation of invasion, replication, and
transmission processes is altered, virulence can emerge (71). Indeed, genome reduction
via gene loss and pseudogenization associated with enhanced pathogenicity has been
described for other bacteria, such as Rickettsia spp., Shigella spp., and Yersinia spp. (71).
Genome reduction through the loss of genes, potentially interfering with host infection,
has also been proposed for S. suis (35). Therefore, as the elimination of the genetic
marker associated with asymptomatic carriage from the GLM could not be done
without a statistically significant loss of fit, it was retained and its usefulness was
evaluated.
In conclusion, we foresee a useful clinical application of our pathotyping tool in
preventative programs aimed at monitoring the health status of pigs and identification
of subclinical carriers of invasive disease-associated S. suis strains in the upper respira-
tory tract. Our approach can easily be updated to incorporate global strain collections
(such as strains from North America and Southeast Asia) to identify geographically
dependent phenotypes. This could contribute to a lower prevalence of disease attrib-
uted to S. suis among pig populations and consequently a reduction in the usage of
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antibiotics in the swine industry, as well as a reduction in zoonotic transmission of this
pathogen through improved surveillance of pig populations.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/JCM
.01712-18.
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